20/20 HealthCare Partners
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact

20/20 HealthCare Partners

22 Dec2020

Variantyx Licenses IBM Technologies That Leverage AI for Somatic Analysis

Written by 2020HCP.com. Posted in News

Variantyx, the leader in high complexity hereditary disease testing, today announced that it has entered into a licensing agreement with IBM for technologies that leverage artificial intelligence for somatic analysis from which Variantyx intends to develop comprehensive tumor diagnostic solutions.

“Variantyx’s proprietary whole genome sequencing (WGS)-based methodology has transformed genetic testing and personalized medicine for pediatric and adult neurological disorders and rare, undiagnosed diseases,” said Haim Neerman, CEO of Variantyx. “This license agreement will accelerate development of a similarly transformative, cancer diagnostic solution.”

“We are pleased to support Variantyx as they work to advance the use of genomics to help scale precision medicine and meet the growing needs of personalized care,” said Ajay Royyuru, Vice President, Healthcare & Life Sciences Research, IBM.

Latest News

  • SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting June 21, 2022
  • SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors April 28, 2022
  • SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo April 11, 2022
  • SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes April 5, 2022
  • Verizon, Bloomberg Media, Zixi & AWS test how 5G & edge compute can transform broadcast February 23, 2022

20/20 HealthCare Partners | 2000 Commonwealth Ave, Suite 200, Auburndale, MA 02466 | Contact Us

Copyright © 2019
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact